World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
51
Citations
7772
World Ranking
17325
National Ranking
743

André Pèlegrin publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where André Pèlegrin sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 219 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

André Pèlegrin D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where André Pèlegrin sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 51 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

André Pèlegrin is affiliated with the University of Montpellier in France and conducts research primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work focuses on key subfields including Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology, Biotechnology, and Reproductive Medicine.

The scientific contributions of André Pèlegrin have appeared in several specialized venues. Frequent publication outlets include:

  • Cancers
  • Clinical Cancer Research
  • Scientific Reports
  • JAMA Network Open
  • mAbs

Their research topics emphasize monoclonal and polyclonal antibodies research, HER2/EGFR in cancer research, and cancer research and treatments. Other notable topics covered are peptidase inhibition and analysis, cancer cells and metastasis, radiopharmaceutical chemistry and applications, and lung cancer treatments and mutations.

Key recent publications by André Pèlegrin include:

  • "Multimodal CEA-Targeted Image-Guided Colorectal Cancer Surgery using 111In-Labeled SGM-101," 2020, published in Clinical Cancer Research
  • "Improving Patients' Life Quality after Radiotherapy Treatment by Predicting Late Toxicities," 2022, published in Cancers
  • "Improving Biologics' Effectiveness in Clinical Oncology: From the Combination of Two Monoclonal Antibodies to Oligoclonal Antibody Mixtures," 2021, published in Cancers
  • "Anti-Müllerian hormone (AMH) autocrine signaling promotes survival and proliferation of ovarian cancer cells," 2021, published in Scientific Reports
  • "Carcinoembryonic Antigen-Related Cell Adhesion Molecule Type 5 Receptor-Targeted Fluorescent Intraoperative Molecular Imaging Tracer for Lung Cancer," 2023, published in JAMA Network Open

Collaborations play a significant role in their research activities. Frequent co-authors include:

  • Thierry Chardès
  • Françoise Cailler
  • Christel Larbouret
  • Véronique Garambois
  • Bérénice Framery

Best Publications

  • Cell-penetrating and cell-targeting peptides in drug delivery.

    Eric Vivès;Julien Schmidt;André Pèlegrin

  • Clinical radioimmunotherapy—the role of radiobiology

    Jean-Pierre Pouget;Isabelle Navarro-Teulon;Manuel Bardiès;Nicolas Chouin

  • Antibody-Indocyanin Conjugates for Immunophotodetection of Human Squamous Cell Carcinoma in Nude Mice

    S. Folli;P. Westermann;D. Braichotte;A. Pèlegrin

  • Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study.

    Leonora S F Boogerd;Charlotte E S Hoogstins;Dennis P Schaap;Miranda Kusters

  • Anti-HER2 vaccines: new prospects for breast cancer therapy

    Maha Zohra Ladjemi;William Jacot;Thierry Chardès;André Pèlegrin

  • Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy

    David Azria;Mahmut Ozsahin;Andrew Kramar;Sheila Peters

  • Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent.

    Charlotte E. S. Hoogstins;Leonora S. F. Boogerd;Babs G. Sibinga Mulder;J. Sven D. Mieog

  • The development and characterisation of porphyrin isothiocyanate–monoclonal antibody conjugates for photoimmunotherapy

    R Hudson;M Carcenac;K Smith;L Madden

  • Tumor-necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by increasing vascular permeability.

    S. Folli;A. Pelegrin;Y. Chalandon;Xiaofei Yao

  • In vivo therapeutic synergism of anti-epidermal growth factor receptor and anti-HER2 monoclonal antibodies against pancreatic carcinomas.

    Christel Larbouret;Bruno Robert;Isabelle Navarro-Teulon;Simon Thèzenas

  • Immunophotodiagnosis of colon carcinomas in patients injected with fluoresceinated chimeric antibodies against carcinoembryonic antigen.

    S Folli;G Wagnières;A Pèlegrin;J M Calmes

  • Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients.

    D Azria;S Gourgou;W J Sozzi;A Zouhair

  • Iodine-131-labeled MAb F(ab')2 fragments are more efficient and less toxic than intact anti-CEA antibodies in radioimmunotherapy of large human colon carcinoma grafted in nude mice

    Franz Buchegger;André Pèlegrin;Bernard Delaloye;Angelika Bischof-Delaloye

  • Radiation-induced CD8 T-lymphocyte Apoptosis as a Predictor of Breast Fibrosis After Radiotherapy: Results of the Prospective Multicenter French Trial.

    David Azria;Olivier Riou;Florence Castan;Tan Dat Nguyen

  • Cell Membrane is a More Sensitive Target than Cytoplasm to Dense Ionization Produced by Auger Electrons.

    Jean-Pierre Pouget;Jean-Pierre Pouget;Jean-Pierre Pouget;Lore Santoro;Laure Raymond;Nicolas Chouin

  • Antibody-fluorescein conjugates for photoimmunodiagnosis of human colon carcinoma in nude mice.

    André Pèlegrin;Silvio Folli;Franz Buchegger;Jean-Pierre Mach

  • Time-resolved Fluorescence Resonance Energy Transfer (TR-FRET) to Analyze the Disruption of EGFR/HER2 Dimers A NEW METHOD TO EVALUATE THE EFFICIENCY OF TARGETED THERAPY USING MONOCLONAL ANTIBODIES

    Nadège Gaborit;Christel Larbouret;Julie Vallaghe;Frédéric Peyrusson

  • In Pancreatic Carcinoma, Dual EGFR/HER2 Targeting with Cetuximab/Trastuzumab Is More Effective than Treatment with Trastuzumab/Erlotinib or Lapatinib Alone: Implication of Receptors' Down-regulation and Dimers' Disruption

    Christel Larbouret;Nadège Gaborit;Thierry Chardès;Mickaël Coelho

  • Single-Domain Antibody–Based and Linker-Free Bispecific Antibodies Targeting FcγRIII Induce Potent Antitumor Activity without Recruiting Regulatory T Cells

    Caroline Rozan;Amélie Cornillon;Corinne Pétiard;Martine Chartier

  • Cell Penetrating and Cell Targeting Peptides in Drug Delivery (revised version)

    Eric Vivès;Julien Schmidt;André Pèlegrin

Frequent Co-Authors

Jean-Pierre Mach
Jean-Pierre Mach University of Lausanne
Jean-Luc Teillaud
Jean-Luc Teillaud Grenoble Alpes University
Jacques Barbet
Jacques Barbet University of Nantes
Charles Theillet
Charles Theillet University of Montpellier
Hervé Bazin
Hervé Bazin Université Catholique de Louvain
Christoph Heusser
Christoph Heusser Novartis (Switzerland)
Jean-Marc Pascussi
Jean-Marc Pascussi University of Montpellier
Frédérique Penault-Llorca
Frédérique Penault-Llorca University of Clermont Auvergne
Jean Martinez
Jean Martinez University of Montpellier
Christophe Arnoult
Christophe Arnoult Grenoble Alpes University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry opens numerous opportunities for advancement through online education. Many professionals in healthcare and science fields choose to boost their credentials and flexibility by enrolling in specialized online programs.

For nurses aiming to expand their skills, there are efficient options such as the shortest post master's pmhnp online programs or the shortest post master's fnp program. These certificates can fast-track careers in psychiatric-mental health or family nurse practice.

Nutrition is another in-demand field. Those interested in dietetics might benefit from the cheapest online nutrition degree options, which make it easier to begin or advance a career in health and wellness without excessive debt.

Registered nurses seeking to further their education can opt for rn to bsn online programs, making the transition to advanced roles more accessible and manageable while working. These pathways help bridge the gap between undergraduate study and specialized, high-demand positions.

Best Scientists Citing André Pèlegrin

Trending Scientists

Recently Published Articles